BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2004
View Archived Issues
LEA-29Y superior to ciclosporin in renal transplantation
Read More
MR tacrolimus can replace standard tacrolimus in liver transplantation
Read More
Visilizumab found effective in refractory ulcerative colitis
Read More
BPC-157 reported to promote ulcer healing in rats
Read More
Renzapride improves bowel function and reduces abdominal pain/discomfort in IBS
Read More
Novartis reports Q1 regulatory and clinical highlights
Read More
R&D projects proceeding as planned at Actelion
Read More
European orphan drug status for HuMax-CD4 in CTCL
Read More
Progress of dopamine D1-selective antagonist lines up milestones for CeNeS
Read More
IND cleared for phase I trials of GI-4000 series
Read More
Nine-month results from TAXUS VI study
Read More
Positive phase I/II results for CZEN-002 in vulvovaginal candidiasis
Read More
Vertex expands discovery and development collaboration with CFFT
Read More
Basilea to advance BAL-5788 into phase III
Read More
Treatment commences in phase I trial of ATN-224 in solid tumors
Read More
sNDA filed for once-monthly oral formulation of Boniva
Read More
Pivanex enters new phase II studies in CLL and malignant melanoma
Read More
Xifaxan approved for travelers' diarrhea caused by noninvasive E. coli
Read More
WX-UK1 enters phase I trial at Fox Chase
Read More
Intercell signs license agreement with Merck & Co.
Read More
Insulin formulation allows absorption through the gastrointestinal tract
Read More
Pioglitazone improves features of nonalcoholic steatohepatitis
Read More
Aliskiren reported as safe and effective as irbesartan for mild to moderate hypertension
Read More
Cardiovascular benefits of pravastatin in type 2 diabetics
Read More
Monoclonal antibodies against truncated Abeta peptides and their use as diagnostics for AD
Read More
Allergan presents new prostaglandin analogues with utility as ocular hypotensive agents
Read More
New analgesic vanilloid VR1 antagonists emerge from Novartis R&D
Read More
GSK researchers identify chemokine CCR8 receptor antagonists for use in asthma therapy
Read More
Novel retinoid RXR partial agonists claimed as antidiabetic agents by Allergan
Read More
New cathepsin K inhibitors developed at Merck Frosst
Read More
Nissan Chemical scientists design new TPO receptor agonists
Read More
Novel respiratory syncytial virus inhibitor from Arrow Therapeutics
Read More
Small molecule broad spectrum anti-herpes simplex virus
Read More